147 related articles for article (PubMed ID: 32876856)
1. Multidisciplinary and Comprehensive Chinese Medicine for Advanced Non-Small Cell Lung Cancer Patients: A Retrospective Study of 855 Cases.
Huang XG; Zhu LH; Zhou L; Xu WJ; Yao YL; Zhou ZY; Li HG
Chin J Integr Med; 2021 Jul; 27(7):490-495. PubMed ID: 32876856
[TBL] [Abstract][Full Text] [Related]
2. Clinical study on long-term overall survival of advanced non-small-cell lung cancer patients treated with Chinese medicine and Western medicine.
Chen YZ; Feng XB; Li ZD; Zheng WX; Sun H; Li PP
Chin J Integr Med; 2014 Mar; 20(3):179-83. PubMed ID: 24615210
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
[TBL] [Abstract][Full Text] [Related]
4. Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ
Complement Ther Med; 2014 Dec; 22(6):1010-8. PubMed ID: 25453521
[TBL] [Abstract][Full Text] [Related]
5. [Exploration of the rational therapeutic regimen for advanced lung cancer patients with mild tumor enlargement].
Zhang XL; Wang XY; Zhang CC; Yang J; Yuan XH; Li K
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):775-782. PubMed ID: 29061023
[No Abstract] [Full Text] [Related]
6. Prognostic factors in older patients with advanced non-small cell lung cancer in China.
Su Q; Sun YP; Liu YH; Li Z; Yang HY; Sun ZG; Cao BW; Jia JH
Tumori; 2014; 100(1):69-74. PubMed ID: 24675494
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study.
Liu J; Lin HS; Hou W; Hua BJ; Zhang PT; Li J; Wang SY; Xie Y; Zhang Y; Xie GR; Zhang MY; Shi WG; Guan NB; Guan TY; Li CH; Lu LY; Zhang Y; Li DR; Liu H
Chin J Integr Med; 2017 Oct; 23(10):733-739. PubMed ID: 27796823
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival analysis of patients with stage IIIB-IV non-small cell lung cancer complicated by type 2 diabetes mellitus: A retrospective propensity score matching analysis.
Li X; Fang H; Zhang D; Xia L; Wang X; Yang J; Zhang S; Su Y; Zhu Y
Thorac Cancer; 2022 Dec; 13(23):3268-3273. PubMed ID: 36217741
[TBL] [Abstract][Full Text] [Related]
9. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
11. [Value of surgery for stage IIIa non-small cell lung cancer].
Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of integrative treatment for ninety-one elderly patients with advanced non-small cell lung cancer].
You J; Shan MJ; Zhao H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jun; 32(6):774-8. PubMed ID: 22978101
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the efficacy and survival of third-line treatment in advanced non-small cell lung cancer].
Shao L; Song Z; Hu L; Xie F; Lou G; Hong W; Gu C; Hong D; Lin B; Zhang Y
Zhongguo Fei Ai Za Zhi; 2012 Jun; 15(6):369-74. PubMed ID: 22681924
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
[No Abstract] [Full Text] [Related]
15. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for second-line treatment of advanced non-small-cell lung cancer: retrospective analysis at a single institution.
Inal A; Kaplan MA; Kucukoner M; Urakci Z; Karakus A; Isikdogan A
Asian Pac J Cancer Prev; 2012; 13(4):1281-4. PubMed ID: 22799319
[TBL] [Abstract][Full Text] [Related]
17. Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non-small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation.
Qiu B; Liang Y; Li Q; Liu G; Wang F; Chen Z; Liu M; Zhao M; Liu H
Clin Lung Cancer; 2017 Nov; 18(6):e369-e373. PubMed ID: 28465010
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and prognostic factors of 178 advanced non-small lung cancer patients undergoing different second-line chemotherapeutic regimens].
Kong Q; Wang XY; Jiang RC; Ba Y; Li K
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):294-9. PubMed ID: 27087377
[TBL] [Abstract][Full Text] [Related]
19. Application of Response Evaluation Criteria of Traditional Chinese Medicine for Solid Tumor in advanced non-small cell lung cancer.
Xue NZ; Fang RM; Lin LZ
Chin J Integr Med; 2014 Dec; 20(12):910-6. PubMed ID: 25428339
[TBL] [Abstract][Full Text] [Related]
20. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
